Bigul

Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication

The Notice of the Annual General Meeting and E-voting information of the Company published today i.e., 19th April 2023, in newspapers, Business Standard and Sakal.
19-04-2023
Bigul

Sanofi India Ltd - 500674 - Business Responsibility and Sustainability Reporting (BRSR)

Sanofi India - Business Responsibility and Sustainability Report for the year 2022
18-04-2023
Bigul

Sanofi India Ltd - 500674 - Reg. 34 (1) Annual Report.

Pursuant to Regulation 34 (1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the Annual Report for the Financial Year ended 31st December 2022 along with the Notice of the 67th Annual General Meeting (AGM) which is scheduled to be held on 11th May 2023 through Video Conferencing facility / Other Audio-Visual Means for your information and records.
18-04-2023
Bigul

Sanofi India Ltd - 500674 - Announcement under Regulation 30 (LODR)-Newspaper Publication

The newspaper publication related to notice of the Annual General Meeting which will be held through video conferencing facility on 11th May 2023, published today i.e., 18th April 2023, in newspapers, Business Standard and Sakal.
18-04-2023
Bigul

Sanofi India Ltd - 500674 - Announcement Under Regulation 30 - NLEM Communication

Announcement under Regulation 30 - NLEM Communication
11-04-2023
Bigul

Sanofi India Ltd - 500674 - Communication Of Deduction Of Tax At Source On Dividend

Please find enclosed copy of the letter for deduction of tax at source on Dividend sent to the shareholders today i.e., 11th April 2023 through email who have registered their email ID with the Company / Depositories. The said communication is also being made available on the website of the Company at www.sanofiindialtd.com.
11-04-2023
Bigul

Sanofi India Ltd - 500674 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Quarter Ended 31St March 2023

Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2023 ,inter alia, to consider and approve the Unaudited Financial Results for the quarter ended 31st March 2023.
11-04-2023
Bigul

Sanofi India Ltd - 500674 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of the Company has provided certificate for the year ended 31st March 2023 under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
06-04-2023
Bigul

Sanofi India Ltd - 500674 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has received communication from its Registrar and Share Transfer Agent on loss of share certificate.
03-04-2023
Bigul

Sanofi India Ltd - 500674 - Closure of Trading Window

Pursuant to the Company's Code of Conduct to Regulate, Monitor and Report Insider Trading by Designated Persons we would like to inform you that, inter-alia, for the purpose of declaration of financial results of the Company, for the quarter ending 31st March 2023, the trading window of the Company shall remain closed from 1st April 2023 till 48 hours after the announcement of the results to the stock exchanges.
30-03-2023
Next Page
Close

Let's Open Free Demat Account